FANCI and prostate cancer: Our results suggest that the activity of FANCI is needed for a subset of prostate cancer cells to survive under DNA damage-inducing chemotherapy, and FANCI depletion leads to the downregulation of multiple FA pathway genes and thus most likely to the inactivation of the FA pathway in prostate cancer.